Cardlytics (CDLX) Operating Expenses (2017 - 2026)

Cardlytics' Operating Expenses history runs 10 years deep, the most recent figure standing at $42.6 million for Q1 2026.

• Quarterly Operating Expenses fell 36.95% year-over-year to $42.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $301.7 million (down 33.09% YoY) and the FY2025 annual result came in at $335.1 million, down 29.28% from the prior year.
• Operating Expenses was $42.6 million for Q1 2026 at Cardlytics, down from $62.2 million in the prior quarter.
• Across five years, Operating Expenses topped out at $465.1 million in Q4 2022 and bottomed at $32.3 million in Q1 2022.
• A 5-year average of $120.2 million and a median of $85.4 million in 2024 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses jumped 336.92% — and 2023, when it plunged 58.7%.
• Cardlytics' Operating Expenses stood at $465.1 million in 2022, then plunged by 58.7% to $192.1 million in 2023, then tumbled by 57.15% to $82.3 million in 2024, then retreated by 24.45% to $62.2 million in 2025, then slumped by 31.51% to $42.6 million in 2026.
• Business Quant data shows CDLX's Operating Expenses at $42.6 million in Q1 2026, $62.2 million in Q4 2025, and $120.9 million in Q3 2025.